nodes	percent_of_prediction	percent_of_DWPC	metapath
Bromocriptine—ABCB1—Topotecan—cervical cancer	0.226	0.625	CbGbCtD
Bromocriptine—CYP3A4—Topotecan—cervical cancer	0.135	0.375	CbGbCtD
Bromocriptine—ADRA1D—epithelium—cervical cancer	0.00763	0.0396	CbGeAlD
Bromocriptine—ADRA1B—renal system—cervical cancer	0.00723	0.0375	CbGeAlD
Bromocriptine—DRD5—female reproductive system—cervical cancer	0.00707	0.0367	CbGeAlD
Bromocriptine—DRD5—female gonad—cervical cancer	0.00643	0.0334	CbGeAlD
Bromocriptine—ADRA1D—female reproductive system—cervical cancer	0.00567	0.0294	CbGeAlD
Bromocriptine—HTR2B—uterine cervix—cervical cancer	0.00526	0.0273	CbGeAlD
Bromocriptine—HTR2B—decidua—cervical cancer	0.00501	0.026	CbGeAlD
Bromocriptine—HTR2B—endometrium—cervical cancer	0.00476	0.0247	CbGeAlD
Bromocriptine—HTR7—epithelium—cervical cancer	0.00454	0.0236	CbGeAlD
Bromocriptine—HTR1A—renal system—cervical cancer	0.00441	0.0229	CbGeAlD
Bromocriptine—HTR2B—uterus—cervical cancer	0.00438	0.0227	CbGeAlD
Bromocriptine—ADRA1A—epithelium—cervical cancer	0.00438	0.0227	CbGeAlD
Bromocriptine—HTR1B—female reproductive system—cervical cancer	0.00437	0.0227	CbGeAlD
Bromocriptine—HTR1D—female reproductive system—cervical cancer	0.00424	0.022	CbGeAlD
Bromocriptine—HTR7—renal system—cervical cancer	0.00421	0.0219	CbGeAlD
Bromocriptine—HTR2C—female reproductive system—cervical cancer	0.00419	0.0218	CbGeAlD
Bromocriptine—ADRA2C—uterine cervix—cervical cancer	0.00414	0.0215	CbGeAlD
Bromocriptine—ADRB1—female reproductive system—cervical cancer	0.00412	0.0214	CbGeAlD
Bromocriptine—ADRA1A—renal system—cervical cancer	0.00406	0.0211	CbGeAlD
Bromocriptine—ADRA2C—decidua—cervical cancer	0.00394	0.0205	CbGeAlD
Bromocriptine—HTR2B—female reproductive system—cervical cancer	0.00394	0.0204	CbGeAlD
Bromocriptine—ADRA2C—renal system—cervical cancer	0.00387	0.0201	CbGeAlD
Bromocriptine—ADRA2C—endometrium—cervical cancer	0.00374	0.0194	CbGeAlD
Bromocriptine—ADRA2C—mammalian vulva—cervical cancer	0.00362	0.0188	CbGeAlD
Bromocriptine—HTR2B—vagina—cervical cancer	0.00356	0.0185	CbGeAlD
Bromocriptine—ADRA2C—uterus—cervical cancer	0.00345	0.0179	CbGeAlD
Bromocriptine—HTR7—female reproductive system—cervical cancer	0.00337	0.0175	CbGeAlD
Bromocriptine—CYP1A2—renal system—cervical cancer	0.00336	0.0174	CbGeAlD
Bromocriptine—ADRA2A—uterine cervix—cervical cancer	0.0033	0.0171	CbGeAlD
Bromocriptine—ADRA2A—decidua—cervical cancer	0.00315	0.0163	CbGeAlD
Bromocriptine—ADRA2A—endometrium—cervical cancer	0.00299	0.0155	CbGeAlD
Bromocriptine—ADRA2A—mammalian vulva—cervical cancer	0.00289	0.015	CbGeAlD
Bromocriptine—HTR2A—epithelium—cervical cancer	0.00283	0.0147	CbGeAlD
Bromocriptine—ADRA2C—female gonad—cervical cancer	0.00282	0.0146	CbGeAlD
Bromocriptine—ADRA2C—vagina—cervical cancer	0.0028	0.0146	CbGeAlD
Bromocriptine—ADRA2A—uterus—cervical cancer	0.00275	0.0143	CbGeAlD
Bromocriptine—HTR2A—renal system—cervical cancer	0.00263	0.0136	CbGeAlD
Bromocriptine—ADRA2A—female reproductive system—cervical cancer	0.00247	0.0128	CbGeAlD
Bromocriptine—CYP3A4—renal system—cervical cancer	0.00243	0.0126	CbGeAlD
Bromocriptine—HTR2B—lymph node—cervical cancer	0.0023	0.012	CbGeAlD
Bromocriptine—ADRA2A—female gonad—cervical cancer	0.00225	0.0117	CbGeAlD
Bromocriptine—ADRA2A—vagina—cervical cancer	0.00224	0.0116	CbGeAlD
Bromocriptine—HTR2A—female reproductive system—cervical cancer	0.0021	0.0109	CbGeAlD
Bromocriptine—CYP3A4—female reproductive system—cervical cancer	0.00195	0.0101	CbGeAlD
Bromocriptine—HTR2A—vagina—cervical cancer	0.0019	0.00987	CbGeAlD
Bromocriptine—ABCB1—epithelium—cervical cancer	0.00186	0.00963	CbGeAlD
Bromocriptine—ABCB1—uterine cervix—cervical cancer	0.00184	0.00955	CbGeAlD
Bromocriptine—ADRA2C—lymph node—cervical cancer	0.00181	0.00941	CbGeAlD
Bromocriptine—ABCB1—decidua—cervical cancer	0.00175	0.0091	CbGeAlD
Bromocriptine—ABCB1—renal system—cervical cancer	0.00172	0.00893	CbGeAlD
Bromocriptine—ABCB1—endometrium—cervical cancer	0.00166	0.00864	CbGeAlD
Bromocriptine—ABCB1—mammalian vulva—cervical cancer	0.00161	0.00835	CbGeAlD
Bromocriptine—ABCB1—uterus—cervical cancer	0.00153	0.00796	CbGeAlD
Bromocriptine—ADRA2A—lymph node—cervical cancer	0.00145	0.00751	CbGeAlD
Bromocriptine—ABCB1—female reproductive system—cervical cancer	0.00138	0.00715	CbGeAlD
Bromocriptine—ABCB1—female gonad—cervical cancer	0.00125	0.00651	CbGeAlD
Bromocriptine—ABCB1—vagina—cervical cancer	0.00125	0.00647	CbGeAlD
Bromocriptine—ABCB1—lymph node—cervical cancer	0.000807	0.00418	CbGeAlD
Bromocriptine—DRD5—Signaling Pathways—TERT—cervical cancer	0.000156	0.000351	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000156	0.000349	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NOTCH2—cervical cancer	0.000153	0.000344	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000153	0.000344	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.00015	0.000336	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOTCH2—cervical cancer	0.000145	0.000325	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—CA9—cervical cancer	0.000144	0.000322	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—FGFR3—cervical cancer	0.000144	0.000322	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000143	0.00032	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOTCH2—cervical cancer	0.000143	0.00032	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—cervical cancer	0.000142	0.000318	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—WNT5A—cervical cancer	0.000139	0.000313	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—HES1—cervical cancer	0.000138	0.000309	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—HES1—cervical cancer	0.000138	0.000309	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—HES1—cervical cancer	0.000137	0.000307	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—NOTCH1—cervical cancer	0.000135	0.000302	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—HES1—cervical cancer	0.000134	0.0003	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—HES1—cervical cancer	0.000132	0.000296	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOTCH2—cervical cancer	0.00013	0.000292	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOTCH2—cervical cancer	0.000129	0.000289	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—HES1—cervical cancer	0.000126	0.000282	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000124	0.000279	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000124	0.000278	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TERT—cervical cancer	0.000121	0.000271	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TERT—cervical cancer	0.000121	0.000271	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOTCH2—cervical cancer	0.00012	0.00027	CbGpPWpGaD
Bromocriptine—DRD5—Signaling by GPCR—EGFR—cervical cancer	0.00012	0.000269	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TERT—cervical cancer	0.00012	0.000269	CbGpPWpGaD
Bromocriptine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—cervical cancer	0.000119	0.000267	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—HES1—cervical cancer	0.000119	0.000266	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000119	0.000266	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TERT—cervical cancer	0.000117	0.000263	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000117	0.000263	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—HES1—cervical cancer	0.000117	0.000263	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TERT—cervical cancer	0.000116	0.000259	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—CA9—cervical cancer	0.000115	0.000257	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000111	0.000249	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—FGFR3—cervical cancer	0.000111	0.000248	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TERT—cervical cancer	0.00011	0.000247	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—FGFR3—cervical cancer	0.00011	0.000247	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000109	0.000245	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—FGFR3—cervical cancer	0.000108	0.000242	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000108	0.000241	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—HES1—cervical cancer	0.000107	0.000239	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—FGFR3—cervical cancer	0.000106	0.000238	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—HES1—cervical cancer	0.000106	0.000237	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000105	0.000236	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.000104	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2B—Hemostasis—TP53—cervical cancer	0.000104	0.000233	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TERT—cervical cancer	0.000104	0.000233	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—NOTCH1—cervical cancer	0.000104	0.000233	CbGpPWpGaD
Bromocriptine—ADRA2C—Metabolism—MTHFR—cervical cancer	0.000104	0.000233	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—NOTCH1—cervical cancer	0.000103	0.000232	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000103	0.00023	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TERT—cervical cancer	0.000103	0.00023	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000102	0.000229	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000102	0.000228	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—FGFR3—cervical cancer	0.000101	0.000227	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—NOTCH1—cervical cancer	0.000101	0.000227	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—MTOR—cervical cancer	0.000101	0.000227	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—NOTCH1—cervical cancer	9.95e-05	0.000223	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—HES1—cervical cancer	9.87e-05	0.000221	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOTCH2—cervical cancer	9.78e-05	0.000219	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—HES1—cervical cancer	9.72e-05	0.000218	CbGpPWpGaD
Bromocriptine—ADRA2C—Hemostasis—TP53—cervical cancer	9.72e-05	0.000218	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—FGFR3—cervical cancer	9.54e-05	0.000214	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—NOTCH1—cervical cancer	9.5e-05	0.000213	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	9.42e-05	0.000211	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—FGFR3—cervical cancer	9.42e-05	0.000211	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TERT—cervical cancer	9.35e-05	0.00021	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CASP3—cervical cancer	9.29e-05	0.000208	CbGpPWpGaD
Bromocriptine—HTR6—Signaling by GPCR—EGFR—cervical cancer	9.27e-05	0.000208	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TERT—cervical cancer	9.26e-05	0.000208	CbGpPWpGaD
Bromocriptine—HTR7—Signaling by GPCR—EGFR—cervical cancer	9.26e-05	0.000208	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling by GPCR—EGFR—cervical cancer	9.2e-05	0.000206	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling by GPCR—EGFR—cervical cancer	9.01e-05	0.000202	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—HES1—cervical cancer	8.96e-05	0.000201	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—NOTCH1—cervical cancer	8.96e-05	0.000201	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—CTNNB1—cervical cancer	8.96e-05	0.000201	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TERT—cervical cancer	8.94e-05	0.000201	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TERT—cervical cancer	8.9e-05	0.0002	CbGpPWpGaD
Bromocriptine—DRD4—Signaling by GPCR—EGFR—cervical cancer	8.87e-05	0.000199	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—CA9—cervical cancer	8.85e-05	0.000198	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	8.84e-05	0.000198	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—NOTCH1—cervical cancer	8.84e-05	0.000198	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—HES1—cervical cancer	8.82e-05	0.000198	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TERT—cervical cancer	8.65e-05	0.000194	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—HES1—cervical cancer	8.63e-05	0.000194	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—FGFR3—cervical cancer	8.58e-05	0.000192	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TERT—cervical cancer	8.52e-05	0.000191	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—FGFR3—cervical cancer	8.5e-05	0.000191	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling by GPCR—EGFR—cervical cancer	8.46e-05	0.00019	CbGpPWpGaD
Bromocriptine—ADRA2A—Metabolism—MTHFR—cervical cancer	8.43e-05	0.000189	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—FGFR3—cervical cancer	8.21e-05	0.000184	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—FGFR3—cervical cancer	8.16e-05	0.000183	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—NOTCH1—cervical cancer	8.05e-05	0.000181	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—HES1—cervical cancer	8.02e-05	0.00018	CbGpPWpGaD
Bromocriptine—DRD1—Signaling by GPCR—EGFR—cervical cancer	7.98e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—NOTCH1—cervical cancer	7.98e-05	0.000179	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—FGFR3—cervical cancer	7.94e-05	0.000178	CbGpPWpGaD
Bromocriptine—ADRA2A—Hemostasis—TP53—cervical cancer	7.89e-05	0.000177	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	7.88e-05	0.000177	CbGpPWpGaD
Bromocriptine—DRD3—Signaling by GPCR—EGFR—cervical cancer	7.88e-05	0.000177	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TERT—cervical cancer	7.85e-05	0.000176	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	7.81e-05	0.000175	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—STAT3—cervical cancer	7.81e-05	0.000175	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—MTOR—cervical cancer	7.8e-05	0.000175	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—MTOR—cervical cancer	7.79e-05	0.000175	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—MTOR—cervical cancer	7.74e-05	0.000174	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TERT—cervical cancer	7.72e-05	0.000173	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	7.7e-05	0.000173	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	7.66e-05	0.000172	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—MTOR—cervical cancer	7.58e-05	0.00017	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TERT—cervical cancer	7.56e-05	0.00017	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—MTOR—cervical cancer	7.46e-05	0.000167	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—NOTCH1—cervical cancer	7.45e-05	0.000167	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	7.34e-05	0.000165	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—FGFR3—cervical cancer	7.2e-05	0.000162	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling by GPCR—EGFR—cervical cancer	7.18e-05	0.000161	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CASP3—cervical cancer	7.17e-05	0.000161	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CASP3—cervical cancer	7.16e-05	0.000161	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—MTOR—cervical cancer	7.12e-05	0.00016	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CASP3—cervical cancer	7.12e-05	0.00016	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling by GPCR—EGFR—cervical cancer	7.11e-05	0.000159	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—EGFR—cervical cancer	7.1e-05	0.000159	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—FGFR3—cervical cancer	7.09e-05	0.000159	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TERT—cervical cancer	7.03e-05	0.000158	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CASP3—cervical cancer	6.97e-05	0.000156	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	6.94e-05	0.000156	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—CTNNB1—cervical cancer	6.91e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—CTNNB1—cervical cancer	6.91e-05	0.000155	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling by GPCR—EGFR—cervical cancer	6.86e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—CTNNB1—cervical cancer	6.86e-05	0.000154	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CASP3—cervical cancer	6.86e-05	0.000154	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling by GPCR—EGFR—cervical cancer	6.83e-05	0.000153	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—NOTCH1—cervical cancer	6.76e-05	0.000152	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—CTNNB1—cervical cancer	6.72e-05	0.000151	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—MTOR—cervical cancer	6.71e-05	0.000151	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	6.66e-05	0.000149	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling by GPCR—EGFR—cervical cancer	6.64e-05	0.000149	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—MTOR—cervical cancer	6.62e-05	0.000149	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—MTOR—cervical cancer	6.62e-05	0.000149	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—CTNNB1—cervical cancer	6.61e-05	0.000148	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CASP3—cervical cancer	6.55e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	6.54e-05	0.000147	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	6.52e-05	0.000146	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—FGFR3—cervical cancer	6.45e-05	0.000145	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—CTNNB1—cervical cancer	6.31e-05	0.000142	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CASP3—cervical cancer	6.17e-05	0.000138	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CASP3—cervical cancer	6.09e-05	0.000137	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CASP3—cervical cancer	6.09e-05	0.000137	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—NOTCH1—cervical cancer	6.05e-05	0.000136	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—MTOR—cervical cancer	6.04e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—STAT3—cervical cancer	6.03e-05	0.000135	CbGpPWpGaD
Bromocriptine—DRD2—Signaling by GPCR—EGFR—cervical cancer	6.03e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—STAT3—cervical cancer	6.02e-05	0.000135	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—STAT3—cervical cancer	5.98e-05	0.000134	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—MTOR—cervical cancer	5.98e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD5—Signaling Pathways—TP53—cervical cancer	5.96e-05	0.000134	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—CTNNB1—cervical cancer	5.95e-05	0.000133	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling by GPCR—EGFR—cervical cancer	5.93e-05	0.000133	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	5.87e-05	0.000132	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—CTNNB1—cervical cancer	5.87e-05	0.000132	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—STAT3—cervical cancer	5.86e-05	0.000131	CbGpPWpGaD
Bromocriptine—ABCB1—Metabolism—MTHFR—cervical cancer	5.83e-05	0.000131	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	5.81e-05	0.00013	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—MTOR—cervical cancer	5.77e-05	0.000129	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—STAT3—cervical cancer	5.76e-05	0.000129	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—MTOR—cervical cancer	5.74e-05	0.000129	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—MTOR—cervical cancer	5.59e-05	0.000125	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CASP3—cervical cancer	5.55e-05	0.000125	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—STAT3—cervical cancer	5.5e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CASP3—cervical cancer	5.5e-05	0.000123	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—MTOR—cervical cancer	5.5e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—EGFR—cervical cancer	5.48e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—EGFR—cervical cancer	5.47e-05	0.000123	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—EGFR—cervical cancer	5.44e-05	0.000122	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling by GPCR—EGFR—cervical cancer	5.39e-05	0.000121	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—CTNNB1—cervical cancer	5.35e-05	0.00012	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—EGFR—cervical cancer	5.32e-05	0.000119	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CASP3—cervical cancer	5.31e-05	0.000119	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—CTNNB1—cervical cancer	5.3e-05	0.000119	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CASP3—cervical cancer	5.28e-05	0.000118	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—EGFR—cervical cancer	5.24e-05	0.000117	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—STAT3—cervical cancer	5.19e-05	0.000116	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CASP3—cervical cancer	5.14e-05	0.000115	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—STAT3—cervical cancer	5.12e-05	0.000115	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—STAT3—cervical cancer	5.12e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	5.12e-05	0.000115	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	5.09e-05	0.000114	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—MTOR—cervical cancer	5.07e-05	0.000114	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CASP3—cervical cancer	5.06e-05	0.000113	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—EGFR—cervical cancer	5e-05	0.000112	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—MTOR—cervical cancer	4.99e-05	0.000112	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—CTNNB1—cervical cancer	4.95e-05	0.000111	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—MTOR—cervical cancer	4.88e-05	0.00011	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	4.87e-05	0.000109	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—EGFR—cervical cancer	4.72e-05	0.000106	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—STAT3—cervical cancer	4.66e-05	0.000105	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CASP3—cervical cancer	4.66e-05	0.000105	CbGpPWpGaD
Bromocriptine—CYP1A2—Metabolism—MTHFR—cervical cancer	4.65e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—EGFR—cervical cancer	4.65e-05	0.000104	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—EGFR—cervical cancer	4.65e-05	0.000104	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—STAT3—cervical cancer	4.62e-05	0.000104	CbGpPWpGaD
Bromocriptine—HTR6—Signaling Pathways—TP53—cervical cancer	4.6e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR7—Signaling Pathways—TP53—cervical cancer	4.59e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CASP3—cervical cancer	4.59e-05	0.000103	CbGpPWpGaD
Bromocriptine—HTR1D—Signaling Pathways—TP53—cervical cancer	4.56e-05	0.000102	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—MTOR—cervical cancer	4.54e-05	0.000102	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—CTNNB1—cervical cancer	4.49e-05	0.000101	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CASP3—cervical cancer	4.49e-05	0.000101	CbGpPWpGaD
Bromocriptine—HTR1B—Signaling Pathways—TP53—cervical cancer	4.47e-05	0.0001	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—STAT3—cervical cancer	4.46e-05	0.0001	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—STAT3—cervical cancer	4.44e-05	9.95e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	4.42e-05	9.92e-05	CbGpPWpGaD
Bromocriptine—DRD4—Signaling Pathways—TP53—cervical cancer	4.4e-05	9.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	4.33e-05	9.71e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—STAT3—cervical cancer	4.32e-05	9.68e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—STAT3—cervical cancer	4.25e-05	9.53e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—EGFR—cervical cancer	4.24e-05	9.51e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—EGFR—cervical cancer	4.2e-05	9.42e-05	CbGpPWpGaD
Bromocriptine—HTR2B—Signaling Pathways—TP53—cervical cancer	4.2e-05	9.42e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CASP3—cervical cancer	4.17e-05	9.36e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—EGFR—cervical cancer	4.05e-05	9.09e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—EGFR—cervical cancer	4.03e-05	9.05e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—CTNNB1—cervical cancer	4.02e-05	9.02e-05	CbGpPWpGaD
Bromocriptine—DRD1—Signaling Pathways—TP53—cervical cancer	3.96e-05	8.88e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—EGFR—cervical cancer	3.92e-05	8.8e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—STAT3—cervical cancer	3.92e-05	8.79e-05	CbGpPWpGaD
Bromocriptine—ADRA1D—Signaling Pathways—TP53—cervical cancer	3.91e-05	8.76e-05	CbGpPWpGaD
Bromocriptine—DRD3—Signaling Pathways—TP53—cervical cancer	3.91e-05	8.76e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—EGFR—cervical cancer	3.86e-05	8.66e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—STAT3—cervical cancer	3.85e-05	8.64e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—STAT3—cervical cancer	3.77e-05	8.46e-05	CbGpPWpGaD
Bromocriptine—CYP3A4—Metabolism—MTHFR—cervical cancer	3.59e-05	8.05e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—EGFR—cervical cancer	3.56e-05	7.98e-05	CbGpPWpGaD
Bromocriptine—ADRB1—Signaling Pathways—TP53—cervical cancer	3.56e-05	7.98e-05	CbGpPWpGaD
Bromocriptine—ADRA2B—Signaling Pathways—TP53—cervical cancer	3.53e-05	7.91e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—STAT3—cervical cancer	3.51e-05	7.86e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—EGFR—cervical cancer	3.5e-05	7.86e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—EGFR—cervical cancer	3.43e-05	7.69e-05	CbGpPWpGaD
Bromocriptine—HTR1A—Signaling Pathways—TP53—cervical cancer	3.4e-05	7.64e-05	CbGpPWpGaD
Bromocriptine—HTR2C—Signaling Pathways—TP53—cervical cancer	3.39e-05	7.6e-05	CbGpPWpGaD
Bromocriptine—ADRA2C—Signaling Pathways—TP53—cervical cancer	3.29e-05	7.39e-05	CbGpPWpGaD
Bromocriptine—ADRA1B—Signaling Pathways—TP53—cervical cancer	3.24e-05	7.27e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—EGFR—cervical cancer	3.19e-05	7.15e-05	CbGpPWpGaD
Bromocriptine—DRD2—Signaling Pathways—TP53—cervical cancer	2.99e-05	6.7e-05	CbGpPWpGaD
Bromocriptine—HTR2A—Signaling Pathways—TP53—cervical cancer	2.94e-05	6.6e-05	CbGpPWpGaD
Bromocriptine—ADRA1A—Signaling Pathways—TP53—cervical cancer	2.88e-05	6.46e-05	CbGpPWpGaD
Bromocriptine—ADRA2A—Signaling Pathways—TP53—cervical cancer	2.68e-05	6e-05	CbGpPWpGaD
